Company: BSX
Filing Date: 2025-05-01
Form Type: 10-Q
Source: 0000885725-25-000026
Chunk: 113

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-05-01
Form: 10-Q
Item: Part I, Item 8
Chunk 113
---
 F – SUPPLEMENTAL BALANCE SHEET INFORMATIONComponents of selected captions within our accompanying unaudited consolidated balance sheets are as follows:Trade accounts receivable, net As of(in millions)March 31, 2025December 31, 2024Trade accounts receivable$2,806 $2,667 Allowance for credit losses(113)(109) $2,693 $2,558 The following is a roll forward of our Allowance for credit losses:Three Months Ended March 31,(in millions)20252024Beginning balance$109 $110 Credit loss expense17 9 Write-offs(13)(10)Ending balance$113 $109 

21

Inventories As of(in millions)March 31, 2025December 31, 2024Finished goods$1,805 $1,798 Work-in-process218 193 Raw materials843 819  $2,867 $2,810 Other current assets As of(in millions)March 31, 2025December 31, 2024Restricted cash and restricted cash equivalents$103 $111 Derivative assets221 305 Other432 414  $756 $831 Property, plant and equipment, net As of(in millions)March 31, 2025December 31, 2024Land$145 $144 Buildings and improvements2,096 2,019 Equipment, furniture and fixtures3,781 3,630 Capital in progress1,009 1,035  7,031 6,827 Less: accumulated depreciation3,642 3,533  $3,389 $3,294 Depreciation expense was $106 million for the first quarter of 2025 and $90 million for the first quarter of 2024.Other long-term assets As of(in millions)March 31, 2025December 31, 2024Restricted cash equivalents$91 $80 Operating lease right-of-use assets448 449 Derivative assets11 79 Investments655 555 Indemnification asset187 188 Other443 402  $1,834 $1,754 

22

Accrued expenses As of(in millions)March 31, 2025December 31, 2024Legal reserves$137 $177 Payroll and related liabilities